-

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of ACELYRIN, Inc. (SLRN) Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired ACELYRIN, Inc. (“Acelyrin” or the “Company”) (NASDAQ: SLRN) securities between May 4, 2023 and September 11, 2023, inclusive (the “Class Period”). Acelyrin investors have until January 16, 2024 to file a lead plaintiff motion.

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of ACELYRIN, Inc. (SLRN) Investors

Share

If you are a shareholder who suffered a loss, click here to participate.

In May 2023, Acelyrin conducted its initial public offering (“IPO”), selling 30 million shares of common stock at $18 per share.

On September 11, 2023, after the markets closed, Acelyrin announced top-line results from Part B of a Phase 2b/3 trial of its Hidradenitis Suppurativa (HS) treatment, izokibep, disclosing that izokibep “did not meet statistical significance” in the reduction in abscesses and inflammatory nodules in patients as compared to placebo.

On this news, Acelyrin's stock price fell $17.19, or 61.6%, over the next two consecutive trading days, to close at $10.71 per share on September 13, 2023, thereby injuring investors.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) izokibep was less effective in treating HS than Defendants had led investors to believe; (2) accordingly, Acelyrin overstated izokibep’s clinical and/or commercial prospects; (3) as a result, Acelyrin also overstated the Company’s business prospects post-IPO; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Acelyrin securities during the Class Period, you may move the Court no later than January 16, 2024 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you purchased Acelyrin securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
info@frankcruzlaw.com
www.frankcruzlaw.com

The Law Offices of Frank R. Cruz

NASDAQ:SLRN

Release Summary
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of ACELYRIN, Inc. (SLRN) Investors
Release Versions
$Cashtags

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
info@frankcruzlaw.com
www.frankcruzlaw.com

More News From The Law Offices of Frank R. Cruz

Securities Fraud Lawsuit Filed Against Lennar Corporation: The Law Offices of Frank R. Cruz Outlines Lead Plaintiff Deadline

LOS ANGELES--(BUSINESS WIRE)--A securities class action lawsuit has been filed against Lennar Corporation ("Lennar" or the "Company") (NYSE: LEN) on behalf of investors who purchased or otherwise acquired Lennar Corporation securities from February 7, 2025 to October 2, 2026, inclusive. The Law Offices of Frank R. Cruz today reported the case, Triggs v. Lennar Corporation et al., filed on November 11, 2026 in the U.S. District Court Florida Southern District Court (Case No. 1:26-cv-28015). Lead...

Lost Money on Cardinal Infrastructure Group Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 62.37% Stock Decline

LOS ANGELES--(BUSINESS WIRE)--Cardinal Infrastructure Group Inc. ("Cardinal Infrastructure" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Cardinal Infrastructure Group Inc. (NASDAQ: CDNL), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Cardinal Infrast...

Securities Fraud Lawsuit Filed Against CVRx, Inc.: The Law Offices of Frank R. Cruz Outlines Lead Plaintiff Deadline

LOS ANGELES--(BUSINESS WIRE)--A securities class action lawsuit has been filed against CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX) on behalf of investors who purchased or otherwise acquired CVRx, Inc. securities from July 25, 2023 to August 6, 2026, inclusive. The Law Offices of Frank R. Cruz today reported the case, Oklahoma Police Pension and Retirement System v. CVRx, Inc. et al., filed on November 9, 2026 in the U.S. District Court District of Minnesota (Case No. 0:26-cv-04746). Lea...
Back to Newsroom